VIXARELIMAB
UNII W25GO3A75W

Substance Identification & Data

This profile provides standardized clinical and technical data for Vixarelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W25GO3A75W.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2243320-83-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W25GO3A75W

CAS Registry Number

2243320-83-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIXARELIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C174929

National Cancer Institute reference terminology for clinical and research data.

INN ID

11350

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-42

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vixarelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIXARELIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G (234-PROLINE,303-GLUTAMINE), ANTI-(HUMAN ONCOSTATIN M RECEPTOR SUBUNIT .BETA.) (HUMAN MONOCLONAL KPL-716 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL KPL-716 .LAMBDA.-CHAIN, DIMER

VIXARELIMAB [INN]

VIXARELIMAB [USAN]

VIXARELIMAB [WHO-DD]